LexDanaLexDanabeta
Inventor

Kevin D. McCormick

Inventor
Basking Ridge, NJ, US

Overview

45→
Patents
1993–2018
Patent span
Human necessities
Primary field (CPC A)

Patents· 45 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds41%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
A61KPreparations for medical, dental or toiletry purposes22%
Y02PClimate change mitigation technologies in the production or processing of goods2%
A01NPreservation of bodies of humans or animals or plants or parts thereof1%
C07HSugars1%
C07JSteroids1%
PatentTitleYear
10,138,212Aminoquinazoline compounds as A20189,469,615'Quinoxalines and AZA-quinoxalines as CRTH2 receptor modulators'20169,290,453'Quinolines and aza-quinolines as CRTH2 receptor modulators'20168,927,559'Quinazolinone-type compounds as CRTH2 antagonists'20158,592,383'Cycloalkyl-fused tetrahydroquinolines as CRTH2 receptor modulators'20138,569,312'Biaryl-spiroaminooxzaoline analogues as alpha 2C adrenergic receptor modulators'20138,524,697'C20-C21 substituted glucocorticoid receptor agonists'20138,501,747'Functionally selective alpha2C adrenoreceptor agonists'20138,476,274'Biaryl spiroaminooxazoline analogues as Alpha2C adrenergic receptor modulators'20138,470,863'Derivatives and analogs of chroman as functionally selective ALPHA2C adrenoreceptor agonists'20138,383,818'Functionally selective alpha2C adrenoreceptor agonists'20138,324,213'Biaryl-spiroaminooxazoline analogues as alpha 2C adrenergic receptor modulators'20128,017,642'Functionally selective ALPHA2C adrenoreceptor agonists'20118,003,624'Functionally selective ALPHA2C adrenoreceptor agonists'20117,985,748'ALPHA2C adrenoreceptor agonists'20117,879,880'Substituted aniline derivatives useful as histamine H3 antagonists'20117,846,946'Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists'20107,803,828'Functionally selective alpha2C adrenoreceptor agonists'20107,700,592'α2C adrenoreceptor agonists'20107,638,531'Phenoxypiperidines and analogs thereof useful as histamine H3 antagonists'20097,635,705'Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists'20097,531,660'1-[[1-[(2-amino-6-methyl-4-pyridinyl)methyl]-4-fluoro-4-piperidinyl]carbonyl]-4-[2-(2-pyridinyl)-3H-imidazo[4,5-B]pyridin-3-YL]piperidine and methods of use thereof'20097,408,066'Carbon-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists'20087,332,604'1-[[1-[(2-Amino-6-methyl-4-pyridinyl)methyl]-4-fluoro-4-piperidinyl]carbonyl]-4-[2-(2-pyridinyl)-3H-imidazo[4,5-b]pyridin-3-yl]piperidine'20087,300,941'Non-imidazole compounds'20077,238,688'Piperidine compounds'20077,220,735'Benzimidazolone histamine H3 antagonists'20077,105,505'Benzimidazole derivatives useful as histamine H3 antagonists'20066,951,871'Indole derivatives useful as histamine H3 antagonists'20056,849,621'Piperidine compounds'20056,762,186'Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists'20046,720,328'Non-imidazole compounds'20046,051,575'Piperazino derivatives as neurokinin antagonists'20006,034,251'Phenyl-alkyl-imidazoles'20005,981,520'Piperazino derivatives as neurokinin antagonists'19995,968,929'Piperazino derivatives as neurokinin antagonists'19995,892,039'Piperazino derivatives as neurokinin antagonists'19995,869,488'Piperazino derivatives as neurokinin antagonists'19995,840,725'Substituted oximes, hydrazones and olefins as neurokinin antagonists'19985,795,894'Piperazino derivatives as neurokinn antagonists'19985,783,579'Spiro-substituted azacyclic-substituted piperazino derivatives as neurokinin antagonists'19985,696,267'Substituted oximes, hydrazones and olefins as neurokinin antagonists'19975,691,362'Substituted benzene-fused hetero- and carbocyclics as nuerokinin antagonists'19975,438,130'Fucosylated guanosine disulfates as excitatory amino acid antagonists'19955,185,365'Insect deterrent azamcrolides'1993

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1993–1995Based in Ithaca, NY, US· patent location history
1997–2011Patents assigned to SCHERING CORP (27)· patent assignee history
1997–2007Based in Edison, NJ, US· patent location history
2007–2018Based in Basking Ridge, NJ, US· patent location history
2012–2018Patents assigned to MERCK SHARP & DOHME (12)· patent assignee history
2012–2016Patents assigned to MCCORMICK KEVIN D (9)· patent assignee history
2012–2016Patents assigned to ASLANIAN ROBERT G (8)· patent assignee history
2012–2016Patents assigned to BOYCE CHRISTOPHER W (7)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
SCHERING CORP271997–2011
MERCK SHARP & DOHME122012–2018
MCCORMICK KEVIN Dself92012–2016
ASLANIAN ROBERT G82012–2016
BOYCE CHRISTOPHER W72012–2016
Locations
LocationPatentsSpan
Basking Ridge, New Jersey, US252007–2018
Edison, New Jersey, US181997–2007
Ithaca, New York, US21993–1995